Acadia Pharmaceuticals
ACAD
ACAD
245 hedge funds and large institutions have $2.12B invested in Acadia Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 69 increasing their positions, 88 reducing their positions, and 47 closing their positions.
Holders
245
Holders Change
-17
Holders Change %
-6.49%
% of All Funds
4.14%
Holding in Top 10
2
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
36
Increased
69
Reduced
88
Closed
47
Calls
$25.3M
Puts
$17.4M
Net Calls
+$7.88M
Net Calls Change
-$10.4M
Top Buyers
1 |
RI
1
RTW Investments
New York
|
$59.5M |
2 |
2
Morgan Stanley
New York
|
$44M |
3 |
DTC
3
Deep Track Capital
Greenwich,
Connecticut
|
$24.4M |
4 |
4
State Street
Boston,
Massachusetts
|
$92.9M |
5 |
5
Wellington Management Group
Boston,
Massachusetts
|
$10.8M |